Miraca’s InformTx Treatment Response Platform for IBD Now Includes Testing for Inflectra

Miraca’s InformTx Treatment Response Platform for IBD Now Includes Testing for Inflectra
Miraca Life Sciences‘ InformTx testing helps doctors assess the response of patients with inflammatory bowel disease (IBD) to certain drug treatments. The company has now expanded its therapeutic drug monitoring (TDM) method by adding a test for Inflectra (infliximab). In the U.S., InformTx assesses drug and anti-drug antibody blood levels for the biologic drugs Cimzia

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *